Literature DB >> 16411036

Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure.

Meryl Brod1, Joseph Johnston, Stephen Able, Ralph Swindle.   

Abstract

INTRODUCTION: A growing body of evidence suggests that symptoms of attention-deficit/hyperactivity disorder (ADHD) persist into adulthood and are associated with ongoing impairment and co-morbidity. The absence of a conceptually sound and well-validated ADHD-specific quality-of-life measure has been an obstacle to understanding this impact. To address this gap, the Adult ADHD Quality-of-Life Scale (AAQoL) was developed based on well accepted methods for designing patient reported outcomes. The purpose of this study was to validate the AAQoL.
METHODS: Nine Hundred and Eighty Nine adults in a retrospective cohort study were administered the AAQoL and psychometric validation was conducted according to an a priori statistical analysis plan.
RESULTS: A 29-item AAQoL was found to have robust scale structure with four domains: Life Productivity, Psychological Health, Relationships and Life outlook. Internal consistency was adequate (0.93 for overall, 0.75-0.93 for subscales), and construct and known-groups validity were supported. conclusion: The AAQoL appears to be a valid measure of quality of life for adults with ADHD and can be considered for incorporation into future studies. The ability to quantify the quality-of-life consequences of adult ADHD should facilitate future research, assist clinicians in identifying appropriate treatment targets and contribute to the ultimate goal of improving the well-being and functioning of adults with ADHD.

Entities:  

Mesh:

Year:  2006        PMID: 16411036     DOI: 10.1007/s11136-005-8325-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  16 in total

Review 1.  Assessing health status and quality-of-life instruments: attributes and review criteria.

Authors:  Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Assessing psychiatric impairment in primary care with the Sheehan Disability Scale.

Authors:  A C Leon; M Olfson; L Portera; L Farber; D V Sheehan
Journal:  Int J Psychiatry Med       Date:  1997       Impact factor: 1.210

4.  Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.

Authors:  G Weiss; L Hechtman; T Milroy; T Perlman
Journal:  J Am Acad Child Psychiatry       Date:  1985-03

5.  Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.

Authors:  M L Wolraich; J N Hannah; T Y Pinnock; A Baumgaertel; J Brown
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-03       Impact factor: 8.829

6.  Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.

Authors:  T E Wilens; J Biederman; E Mick; S V Faraone; T Spencer
Journal:  J Nerv Ment Dis       Date:  1997-08       Impact factor: 2.254

7.  Driving anger and other driving-related behaviors in high and low ADHD symptom college students.

Authors:  Tracy Richards; Jerry Deffenbacher; Lee Rosén
Journal:  J Atten Disord       Date:  2002-06       Impact factor: 3.256

8.  Experienced emotion and affect recognition in adult attention-deficit hyperactivity disorder.

Authors:  Lisa J Rapport; Sara R Friedman; Angela Tzelepis; Amy Van Voorhis; Sara L Friedman
Journal:  Neuropsychology       Date:  2002-01       Impact factor: 3.295

Review 9.  A clinical perspective of attention-deficit/hyperactivity disorder into adulthood.

Authors:  Timothy E Wilens; William Dodson
Journal:  J Clin Psychiatry       Date:  2004-10       Impact factor: 4.384

10.  The Patient Health Questionnaire-2: validity of a two-item depression screener.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Med Care       Date:  2003-11       Impact factor: 2.983

View more
  39 in total

1.  The intraindividual impact of ADHD on the transition of adulthood to old age.

Authors:  Florence Philipp-Wiegmann; Petra Retz-Junginger; Wolfgang Retz; Michael Rösler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-05       Impact factor: 5.270

2.  Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members.

Authors:  Ronald C Kessler; Lenard A Adler; Michael J Gruber; Chaitanya A Sarawate; Thomas Spencer; David L Van Brunt
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

3.  Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.

Authors:  Ronald C Kessler; Jennifer Greif Green; Lenard A Adler; Russell A Barkley; Somnath Chatterji; Stephen V Faraone; Matthew Finkelman; Laurence L Greenhill; Michael J Gruber; Mark Jewell; Leo J Russo; Nancy A Sampson; David L Van Brunt
Journal:  Arch Gen Psychiatry       Date:  2010-11

4.  The structure of adult ADHD.

Authors:  Lenard A Adler; Stephen V Faraone; Thomas J Spencer; Patricia Berglund; Samuel Alperin; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2017-02-17       Impact factor: 4.035

5.  Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials.

Authors:  Kimie Sai; Akiomi Yoshida; Tadaaki Hanatani; Takuya Imatoh; Masahiro Takeuchi; Mamoru Narukawa; Hiroshi Watanabe; Yoshiaki Uyama; Yoshiro Saito
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

Review 6.  Developmental context and treatment principles for ADHD among college students.

Authors:  Andrew P Fleming; Robert J McMahon
Journal:  Clin Child Fam Psychol Rev       Date:  2012-12

Review 7.  A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.

Authors:  Martin A Katzman; Tia Sternat
Journal:  CNS Drugs       Date:  2014-11       Impact factor: 5.749

8.  The quality of life of adults with attention deficit hyperactivity disorder: a systematic review.

Authors:  Rashi Agarwal; Matthew Goldenberg; Robert Perry; Waguih William IsHak
Journal:  Innov Clin Neurosci       Date:  2012-05

9.  Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL).

Authors:  Louis S Matza; Joseph A Johnston; Douglas E Faries; Karen G Malley; Meryl Brod
Journal:  Qual Life Res       Date:  2007-09-12       Impact factor: 4.147

10.  Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review.

Authors:  Jeffery N Epstein; Margaret D Weiss
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.